Searched for
DRUG MAJOR LUPIN
Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Lupin launches generic anti-diabetic tablets in USPharma major Lupin has launched its generic anti-diabetic medicine in the United States. The medicine is dapagliflozin and metformin hydroc...
- Lupin gets tentative nod from USFDA for generic Sugammadex injectionLupin Ltd, a prominent name in the pharmaceutical world, revealed on Tuesday that it has gained tentative approval from the US health autho...
- Lupin launches generic drug to treat Wilson's disease in US marketThe Mumbai-based drug firm's product is the generic equivalent of Mylan Specialty's Depen tablets, which are indicated for the treatment of...
- Plan to approach USFDA for re-inspection of key plants in next few months: LupinThe US drug regulator, after inspecting the two sites, had expressed concerns over quality-control procedures that include handling of out-...
- Lupin gets warning letter from USFDA for Mandideep facilityShares of Lupin were trading 1.36 per cent lower at Rs 749.15 apiece on BSE.
- Lupin recalls over 23,000 bottles of antibiotic drug in USDrug major Lupin is recalling over 23,000 bottles of an antibiotic drug in the US for being sub-potent, US Food and Drug Administration (US...
- Lupin gets USFDA nod for Asthma drugQuoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.
- Lupin receives US FDA approval for Novartis genericTobramycin inhalation solution USP, 300 mg/5 ml, had sales of $133.6 million in the US as of December 2016, Lupin stated in a release about...
- Lupin launches generic insomnia drug in USDrug major Lupin has launched a generic insomnia drug, Zolpidem Sublingual tablets, in the US market with 180-days of marketing exclusivity.
- Lupin launches generic oral contraceptive tablets in USDrug major Lupin has launched its Tri-Lo-Marzia tablets, an oral contraceptive drug, in the US market after getting approval from the Ameri...
- Lupin appoints Thierry Volle as President of EMEA businessDrug major Lupin has appointed Thierry Volle as President of Europe, the Middle-East & Africa (EMEA) with immediate effect based at the com...
- Drug major Lupin receives ISRS certificationDrug major Lupin Ltd today said the company has received certification for International Sustainability Rating Standard, 8th edition (ISRS)...
- Lupin gets USFDA nod for tuberculosis drugDrug major Lupin said it has received US health regulator's approval to market a generic version of Sanofi Aventis' Rifadin capsules.
- Lupin gets USFDA nod for heart disease drugAccording to IMS Health data, the tablets posted sales of around $ 443.4 million in the US for the twelve months ending March, 2013.
- Lupin gets USFDA nod for diabetes drugLupin has received US health regulator's approval to sell its generic version of Glumetza HCl ER Tablets in US market.
- Lupin gets USFDA nod for oral contraceptive drugLupin said it has received US health regulator's approval to market generic version of Ortho-Novum tablets in the American market.
- Drug major Lupin gets USFDA nod for generic Seasonique tabletsDrug major Lupin today said it has received US health regulator's approval for generic version of Teva Branded Pharm's Seasonique Tablets.
Load More
